510(k) device
Q Distal Access Catheter
Mivi Neuroscience, Inc. · Catheter, Percutaneous, Neurovasculature (QJP, Class II) · First FDA decision Dec 16, 2021, newest Sep 19, 2023Acute ischemic strokeBrain aneurysm
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Q Distal Access"
MAUDE reports
1
Brand "Q Distal Access", since 2015
PubMed studies
0
Mentioning "Q Distal Access"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Q Distal Access Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- Q Distal Access Catheter510(k)
K222948 · Decided Sep 19, 2023 · 357 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
K212402 · Decided Dec 16, 2021 · 136 days after receipt
Device type: Catheter, Percutaneous, Neurovasculature (QJP) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Q Distal Access", any status and sponsor, newest update first.
No registered device study names "Q Distal Access".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Q Distal Access", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code QJP
1,927 reports: 1,580 malfunction, 295 injury, 52 death
Newest reports for this brand
3011410509-2022-00001 · Received Nov 9, 2022
Device type: Catheter, Percutaneous (DQY)
Device problem as coded: Use of Device Problem
Patient problem as coded: Intracranial Hemorrhage
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Q Distal Access"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QJP.
- Route 92 Medical Full Length 046 Access SystemRoute 92 Medical, Inc. · 510(k) 2026
- TracStar LDP Large Distal PlatformImperative Care, Inc. · 510(k) 2024
- Millipede 088 Access CatheterPerfuze, Ltd. · 510(k) 2023
- Trevo Trak 21 MicrocatheterStryker Neurovascular · 510(k) 2026
- Path BgcCrossroads Neurovascular, Inc. · 510(k) 2026
- AXS Lift Intracranial Base CatheterStryker Neurovascular · 510(k) 2026
- VersaD Delivery CatheterUnity Medical, Inc. · 510(k) 2025
- Radical the Dude 8F Guide CatheterMaduro Medical, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.